Note 13 Stock-Based Compensation (Tables)

9 Months Ended

Jul. 01, 2023

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]

	Three Months Ended				Nine Months Ended
	July 1, 2023		July 2, 2022		July 1, 2023		July 2, 2022
	(In thousands)
Cost of sales	$	4,518	$	3,724	$	12,785	$	10,455
Selling, general and administrative	8,588		6,819		24,034		18,230
Research and development	211		140		641		360
Total	$	13,317	$	10,683	$	37,460	$	29,045

Schedule of Restricted Stock Units Award Activity [Table Text Block]

	Number of Shares	Weighted- Average Grant Date Fair Value ($)	Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value ($)
	(In thousands)			(In thousands)
Outstanding as of October 1, 2022	3,280	37.11	1.35	155,049
Granted	952	59.88
Vested/Forfeited/Cancelled	(1,309)	36.09
Outstanding as of July 1, 2023	2,923	44.98	1.38	172,287
Expected to vest as of July 1, 2023	2,592	44.51	1.33	152,789